Medicare Launches New GLP-1 Coverage Program Starting July 2026
Beginning July 1, 2026, Medicare will introduce the GLP-1 Bridge program to provide weight loss coverage for eligible beneficiaries at $50 per month. The initiative is set to run through December 31, 2027 and includes specific drugs like Wegovy (injection and tablets) and Zepbound (KwikPen only). Beneficiaries must meet BMI criteria and have a valid prescription with prior authorization.
Topics: GLP-1 drugs Medicare coverage weight loss medications